HS-133, a novel fluorescent phosphatidylinositol 3-kinase inhibitor as a potential imaging and anticancer agent for targeted therapy
Ju‐Hee Lee(Dongguk University), Soon‐Sun Hong(Inha University), Sun‐Mi Yun(CHA University), Sungwoo Hong(Korea Advanced Institute of Science and Technology), Hyunseung Lee(Chonnam National University Hospital), Mi Kwon Son(Korea National University of Transportation), Soyoung Lee(Korea Advanced Institute of Science and Technology), Dong Hee Kim(Samsung Medical Center), Kyeong‐Ryoon Lee(Korea Research Institute of Chemical Technology), Sung‐Hoon Ahn(Korea Research Institute of Chemical Technology), Kyung Hee Jung(Inha University)
Cited by 7
Related Papers
Long-range interaction and correlation between <i>MYC</i> enhancer and oncogenic long noncoding RNA <i>CARLo-5</i>
|Proceedings of the National Academy of Sciences|2014|186
Application of Mesenchymal Stem Cell-Derived Extracellular Vesicles for Stroke: Biodistribution and MicroRNA Study
|Translational Stroke Research|2018|177
Hepatocyte nuclear factor 4α in the intestinal epithelial cells protects against inflammatory bowel disease
|Inflammatory Bowel Diseases|2008|163
Mechanisms of Resistance to Histone Deacetylase Inhibitors
|Advances in cancer research|2012|101